Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1Ariana N. Renrick(Meharry Medical College), Anil Shanker(Meharry Medical College)Frontiers in ImmunologyFebruary 25, 202110.3389/fimmu.2021.607044Cited by 43SaveCiteExport RISWatch citationsRelated PapersBortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk|Oncotarget|2015|33